A non-radiometric method for measuring serum thymidine kinase activity in malignant lymphoma in dogs

Research in Veterinary Science

Volumn 80, Issue 1, 2006, Pages 17-24

  von Euler, Henrik P ^a   Öhrvik, Anders B ^b,d   Eriksson, Staffan K ^c  

^a SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

^b Diasorin SpA   (Italy)

^c SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

^d Fujirebio Diagnostics Inc   (Sweden)

Author keywords

Dog; ELISA; LDH; Lymphoma; Prognosis; Serum; Staging; Thymidine kinase 1; Tumour marker

Indexed keywords

LACTATE DEHYDROGENASE; THYMIDINE KINASE;

ANIMAL EXPERIMENT; ARTICLE; BLADDER CARCINOMA; BLOOD SAMPLING; BREAST CARCINOMA; CANCER STAGING; CONTROLLED STUDY; CORRELATION COEFFICIENT; DERMATOFIBROMA; DOG DISEASE; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; INTERMETHOD COMPARISON; LACTATE DEHYDROGENASE BLOOD LEVEL; LYMPHOMA; MALE; NONHUMAN; PROGNOSIS; RADIOENZYMATIC ASSAY;

ANIMALS; DOG DISEASES; DOGS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; LYMPHOMA; MALE; NEOPLASM STAGING; RADIOLIGAND ASSAY; THYMIDINE KINASE; TUMOR MARKERS, BIOLOGICAL;

ANIMALIA; CANIS FAMILIARIS;

EID: 27744570541     PISSN: 00345288     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rvsc.2005.05.001     Document Type: Article

References (23)

1. E.S. Arner S. Eriksson Mammalian deoxyribonucleoside kinases Pharmacology & Therapeutics 67 1995 155-186
2. J.M. Bland D.G. Altman Comparing methods of measurement: Why plotting difference against standard method is misleading Lancet 346 1995 1085-1087
3. R.C. Burnett W. Vernau J.F. Modiano C.S. Olver P.F. Moore A.C. Avery Diagnosis of canine lymphoid neoplasia using clonal rearrangements of antigen receptor genes Veterinary Pathology 40 2003 32-41
4. P.G. Greenlee D.A. Filippa F.W. Quimby A.K. Patnaik S.E. Calvano R.E. Matus M. Kimmel A.I. Hurvitz P.H. Lieberman Lymphomas in dogs. A morphologic, immunologic, and clinical study Cancer 66 1990 480-490
5. J.S. Gronowitz H. Hagberg C.F. Kallander B. Simonsson The use of serum deoxythymidine kinase as a prognostic marker, and in the monitoring of patients with non-Hodgkin's lymphoma British Journal of Cancer 47 1983 487-495
6. K.A. Hahn K.P. Freeman M.A. Barnhill E.L. Stephen Serum alpha 1-acid glycoprotein concentrations before and after relapse in dogs with lymphoma treated with doxorubicin Journal of American Veterinary Medical Association 214 1999 1023-1025
7. M. Hallek L. Wanders S. Strohmeyer B. Emmerich Thymidine kinase: A tumor marker with prognostic value for non-Hodgkin's lymphoma and a broad range of potential clinical applications Annals of Hematology 65 1992 1-5
8. Q. He L. Zou P.A. Zhang J.X. Lui S. Skog T. Fornander The clinical significance of thymidine kinase 1 measurement in serum of breast cancer patients using anti-TK1 antibody International Journal of Biological Markers 15 2000 139-146
9. M. Hengstschlager M. Knofler E.W. Mullner E. Ogris E. Wintersberger E. Wawra Different regulation of thymidine kinase during the cell cycle of normal versus DNA tumor virus-transformed cells The Journal of Biological Chemistry 269 1994 13836-13842
10. C.F. Kallander B. Simonsson J.S. Gronowitz K. Nilsson Serum deoxythymidine kinase correlates with peripheral lymphocyte thymidine uptake in chronic lymphocytic leukemia European Journal of Haematology 38 1987 331-337
11. R. Lechowski D. Jagielski M. Hoffmann-Jagielska M. Zmudzka A. Winnicka Alpha-fetoprotein in canine multicentric lymphoma Veterinary Research Communication 26 2002 285-296
12. N. Nakamura Y. Momoi T. Watari T. Yoshino H. Tsujimoto A. Hasegawa Plasma thymidine kinase activity in dogs with lymphoma and leukemia Journal of Veterinary Medical Science 59 1997 957-960
13. A. Öhrvik M. Lindh R. Einarsson J. Grassi S. Eriksson Sensitive nonradiometric method for determining thymidine kinase 1 activity Clinical Chemistry 50 2004 1597-1606
14. L.N. Owen Chapter 9, Lymphoid and haematopoietic tissues (including lymphosarcoma of skin) In: L.N. Owen (Ed.) TNM Classification of Tumours in Domestic Animals first ed. 1980 World Health Organization Geneva, Switzerland 46-47
15. S. Poley P. Stieber V. Nussler H. Pahl A. Fateh-Moghadam Serum thymidine kinase in non-Hodgkin lymphomas with special regard to multiple myeloma Anticancer Research 17 1997 3025-3029
16. F. Ponce J.P. Magnol D. Ledieu T. Marchal V. Turinelli K. Chalvet-Monfray C. Fournel-Fleury Prognostic significance of morphological subtypes in canine malignant lymphomas during chemotherapy Veterinary Journal 167 2004 158-166
17. P.H. Sander S. Hanitsch W. Gehrke A. Öhrvik M. Mack Liaison TK1: Development of a fully automated LIAISON random access analyzer [Abstract] Clinical Chemistry 49 2003 6
18. Statistical Analysis Systems Institute JMP User's Guide Version 5 2002 SAS Insitute Inc. Cary, NC
19. N. Wang Q. He S. Skog S. Eriksson B. Tribukait Investigation on cell proliferation with a new antibody against thymidine kinase 1 Analytical Cellular Pathology 23 2001 11-19
20. D.M. Voeller A. Parr C.J. Allegra Development of human anti-thymidine kinase antibodies Anticancer Drugs 12 2001 555-559
21. H. von Euler R. Einarsson U. Olsson A.-S. Lagerstedt S. Eriksson Serum thymidine kinase activity in dogs with malignant lymphoma. A potent marker for prognosis and monitoring the disease Journal of Veterinary Internal Medicine 18 2004 697-702
22. R. Zanatta O. Abate A. D'Angelo B. Miniscalco A. Mannelli Diagnostic and prognostic value of serum lactate dehydrogenase (LDH) and LDH isoenzymes in canine lymphoma Veterinary Research Communication 27 Suppl 1 2003 449-452
23. F. Zhang X. Shao H. Li J.G. Robison B.K. Murray K.L. O'Neill A monoclonal antibody specific for human thymidine kinase 1 Hybridoma 20 2001 25-34